Tapewire

Nasdaq · USD

PACB

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Export transactions ↓
Tapewire entity
5650
SEC CIK
0001299130
Parsed reports
244

Last 12 months

Inside the activity.

0 purchase rows · 12 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202606
Mar 202603
Apr 202601
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 14, 2017 Filed Jun 15, 2017 20:05 UTC
CORCORAN KEVIN PSVP, Market Development
Exercise / conversionCommon Stock 84,183 $1.96 $164,998.68
Disclosure

SEC source: 0001209191-17-040099 · doc4.xml · nonDerivative · entry 1

CORCORAN KEVIN P · CIK 0001240009 · SVP, Market Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 128,252

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
June 02, 2017 Filed Jun 6, 2017 20:20 UTC
BARNES SUSAN KEVP, CFO and PAO
Exercise / conversionStock Option (right to buy) · Derivative 276,238 $0.00 Strike: $2.27 $0.00
Disclosure

SEC source: 0001209191-17-038121 · doc4.xml · derivative · entry 2

BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,762

Underlying: Common Stock · 276,238 shares

Expires 2023-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 1/60th of the shares subject to the option vest monthly over a five year period, provided that the Reporting Person continues to serve through each vesting date.

Read SEC document
June 02, 2017 Filed Jun 6, 2017 20:20 UTC
BARNES SUSAN KEVP, CFO and PAO
Exercise / conversionCommon Stock 276,238 $2.27 $627,060.26
Disclosure

SEC source: 0001209191-17-038121 · doc4.xml · nonDerivative · entry 1

BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 347,417

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 20:06 UTC
Hunkapiller MichaelDirector · Chairman, CEO & President
Exercise / conversionStock Option (right to buy) · Derivative 500,000 $0.00 Strike: $3.01 $0.00
Disclosure

SEC source: 0001209191-17-037670 · doc4.xml · derivative · entry 2

Hunkapiller Michael · CIK 0001317102 · Director · Chairman, CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2022-01-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable.

Read SEC document
June 01, 2017 Filed Jun 5, 2017 20:06 UTC
Hunkapiller MichaelDirector · Chairman, CEO & President
Exercise / conversionCommon Stock 500,000 $3.01 $1,505,000.00
Disclosure

SEC source: 0001209191-17-037670 · doc4.xml · nonDerivative · entry 1

Hunkapiller Michael · CIK 0001317102 · Director · Chairman, CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,300,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 24, 2017 Filed May 25, 2017 16:13 UTC
Shapiro LucyDirector
GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $3.81 $0.00
Disclosure

SEC source: 0001209191-17-035328 · doc4.xml · derivative · entry 1

Shapiro Lucy · CIK 0001435944 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period.

Read SEC document
May 24, 2017 Filed May 25, 2017 21:28 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $3.81 $0.00
Disclosure

SEC source: 0001209191-17-035512 · doc4.xml · derivative · entry 1

MILLIGAN JOHN F · CIK 0001191589 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period.

Read SEC document
May 24, 2017 Filed May 25, 2017 21:27 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $3.81 $0.00
Disclosure

SEC source: 0001209191-17-035511 · doc4.xml · derivative · entry 1

LIVINGSTON RANDALL S · CIK 0001235118 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period.

Read SEC document
May 24, 2017 Filed May 25, 2017 20:13 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $3.81 $0.00
Disclosure

SEC source: 0001209191-17-035326 · doc4.xml · derivative · entry 1

ORDONEZ KATHY · CIK 0001222643 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period.

Read SEC document
May 24, 2017 Filed May 25, 2017 20:12 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $3.81 $0.00
Disclosure

SEC source: 0001209191-17-035323 · doc4.xml · derivative · entry 1

MOHR MARSHALL · CIK 0001252986 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period.

Read SEC document
May 24, 2017 Filed May 25, 2017 20:04 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $3.81 $0.00
Disclosure

SEC source: 0001209191-17-035312 · doc4.xml · derivative · entry 1

Botstein David · CIK 0001554630 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period.

Read SEC document
May 24, 2017 Filed May 25, 2017 20:05 UTC GrantStock Option (right to buy) · Derivative 25,000 $0.00 Strike: $3.81 $0.00
Disclosure

SEC source: 0001209191-17-035313 · doc4.xml · derivative · entry 1

Ericson William W. · CIK 0001503381 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2027-05-24

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over a one year period.

Read SEC document
March 01, 2017 Filed Jan 16, 2018 21:01 UTC
Phillips James MichaelSVP, Research & Development
PurchaseCommon Stock 3,212 $4.07 $13,077.66
Disclosure

SEC source: 0001209191-18-003564 · doc5.xml · nonDerivative · entry 1

Phillips James Michael · CIK 0001504238 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,922

F1 · shares: Shares were acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
February 15, 2017 Filed Feb 16, 2017 21:04 UTC
CORCORAN KEVIN PSVP, Market Development
GrantStock Option (right to buy) · Derivative 100,000 $0.00 Strike: $5.27 $0.00
Disclosure

SEC source: 0001209191-17-011429 · doc4.xml · derivative · entry 1

CORCORAN KEVIN P · CIK 0001240009 · SVP, Market Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2027-02-15

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date.

Read SEC document
February 15, 2017 Filed Feb 16, 2017 21:04 UTC
Phillips James MichaelSVP, Research & Development
GrantStock Option (right to buy) · Derivative 100,000 $0.00 Strike: $5.27 $0.00
Disclosure

SEC source: 0001209191-17-011427 · doc4.xml · derivative · entry 1

Phillips James Michael · CIK 0001504238 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2027-02-15

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date.

Read SEC document
February 15, 2017 Filed Feb 16, 2017 21:03 UTC
BARNES SUSAN KEVP, CFO and PAO
GrantStock Option (right to buy) · Derivative 250,000 $0.00 Strike: $5.27 $0.00
Disclosure

SEC source: 0001209191-17-011426 · doc4.xml · derivative · entry 1

BARNES SUSAN K · CIK 0001267695 · EVP, CFO and PAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2027-02-15

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date.

Read SEC document
February 15, 2017 Filed Feb 16, 2017 21:03 UTC
Hunkapiller MichaelDirector · Chairman, CEO & President
GrantStock Option (right to buy) · Derivative 400,000 $0.00 Strike: $5.27 $0.00
Disclosure

SEC source: 0001209191-17-011423 · doc4.xml · derivative · entry 1

Hunkapiller Michael · CIK 0001317102 · Director · Chairman, CEO & President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,000

Underlying: Common Stock · 400,000 shares

Expires 2027-02-15

F1 · derivative.exercise_date: The shares subject to the option will vest in equal monthly installments over the next four years, provided that the Reporting Person continues to serve through each vesting date.

Read SEC document
October 28, 2016 Filed Oct 31, 2016 21:01 UTC
Phillips James MichaelSVP, Research & Development
Exercise / conversionStock Option (right to buy) · Derivative 20,000 $0.00 Strike: $2.18 $0.00
Disclosure

SEC source: 0001209191-16-147506 · doc4.xml · derivative · entry 3

Phillips James Michael · CIK 0001504238 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,500

Underlying: Common Stock · 20,000 shares

Expires 2023-02-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/5th of the shares subject to the option vested on February 15, 2014 and the balance of the shares vest monthly thereafter over the next four years, provided that the Reporting Person continues to serve through each vesting date.

Read SEC document
October 28, 2016 Filed Oct 31, 2016 21:01 UTC
Phillips James MichaelSVP, Research & Development
SaleCommon Stock 20,000 $8.44 $168,720.00
Disclosure

SEC source: 0001209191-16-147506 · doc4.xml · nonDerivative · entry 2

Phillips James Michael · CIK 0001504238 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 181,449

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: This is the weighted average price of the shares sold, which ranged from $8.25 to $8.53 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

Read SEC document
October 28, 2016 Filed Oct 31, 2016 21:01 UTC
Phillips James MichaelSVP, Research & Development
Exercise / conversionCommon Stock 20,000 $2.18 $43,600.00
Disclosure

SEC source: 0001209191-16-147506 · doc4.xml · nonDerivative · entry 1

Phillips James Michael · CIK 0001504238 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 201,449

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 01, 2016 Filed Jan 27, 2017 21:13 UTC
Phillips James MichaelSVP, Research & Development
PurchaseCommon Stock 3,147 $4.07 $12,813.01
Disclosure

SEC source: 0001209191-17-005856 · doc5.xml · nonDerivative · entry 2

Phillips James Michael · CIK 0001504238 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 187,710

F1 · shares: Shares were acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
September 01, 2016 Filed Jan 27, 2017 21:12 UTC
CORCORAN KEVIN PSVP, Market Development
PurchaseCommon Stock 1,716 $4.07 $6,986.69
Disclosure

SEC source: 0001209191-17-005854 · doc5.xml · nonDerivative · entry 2

CORCORAN KEVIN P · CIK 0001240009 · SVP, Market Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,455

F1 · shares: Shares were acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
March 01, 2016 Filed Jan 27, 2017 21:13 UTC
Phillips James MichaelSVP, Research & Development
PurchaseCommon Stock 3,114 $4.07 $12,678.65
Disclosure

SEC source: 0001209191-17-005856 · doc5.xml · nonDerivative · entry 1

Phillips James Michael · CIK 0001504238 · SVP, Research & Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 184,563

F1 · shares: Shares were acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document
March 01, 2016 Filed Jan 27, 2017 21:12 UTC
CORCORAN KEVIN PSVP, Market Development
PurchaseCommon Stock 3,503 $4.07 $14,262.46
Disclosure

SEC source: 0001209191-17-005854 · doc5.xml · nonDerivative · entry 1

CORCORAN KEVIN P · CIK 0001240009 · SVP, Market Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,739

F1 · shares: Shares were acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.